Biologics Top Stories UK’s MHRA Accepts Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Assessment byNoah SimmonsSeptember 8, 2026
Recon Top Stories Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center byJosh SandbergSeptember 1, 2026
Recon Top Stories Medacta Introduces NextAR Hip Application to its Proprietary Augmented Reality Platform for Accurate and Efficient Execution of Personalized THA byTim AllenJuly 23, 2026
Biologics Regulatory Sports Medicine Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® byTim AllenApril 29, 2026
Biologics Regulatory CERAMENT® V application in the U.S. transferred to the De Novo process byWill SandbergDecember 2, 2025
Biologics Regulatory Spine BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergNovember 17, 2025
Regulatory Top Stories Bone Biologics Files Patent Application for Bone Regeneration Technology byJosh SandbergJune 27, 2025
Recon Regulatory Sports Medicine Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant byTim AllenMay 20, 2025
Regulatory Spine Waypoint Orthopedics Submits 510(k) Application for Waypoint GPS™ byJosh SandbergJuly 15, 2022
Extremities Regulatory Top Stories Bioretec files for CE mark for its bioresorbable RemeOs magnesium screw in the EU byJosh SandbergDecember 31, 2021
